New Enterprise Electronic Lab Notebook…
September 29, 2008
Symyx Technologies, Inc. has announced the availability of Symyx Notebook - a new, enterprise electronic laboratory notebook (ELN) that is configurable to meet the needs of biologists and analytical chemists out-of-the-box. Symyx Notebook (https://www.symyx.com/downloads/Symyx%20Notebook%20Datasheet.pdf) simplifies laboratory operations and lowers costs by enabling R&D organisations to replace multiple discipline-specific ELNs with a single, multi-discipline application that [...]
September 29, 2008
Applied Biosystems Inc. (NYSE:ABI) today announced that the U.S. Food and Drug Administration has purchased seven of the company's 4000 QTRAP(R) Systems for the analysis of potential harmful pesticides in the U.S. food supply. These systems will be deployed at FDA field offices in Jefferson, Ark.; Irvine, Calif.; Lenexa, Kan.; Jamaica, NY; Bothell, Wash.; Atlanta, [...]
September 29, 2008
LEXINGTON, Mass., Sept. 29 -- RainDance Technologies announced today the launch of the dScreen Consortium, a research initiative conducted with sanofi-aventis, Paris (EURONEXT: SAN and NYSE: SNY), and Louis Pasteur University of Strasbourg, France, to develop the next generation of high-throughput screening (HTS) for drug discovery applications. The consortium was founded with the assistance of [...]
Genetix Appoints Dr. Stephen Game as Head of Research and Development
September 29, 2008
New Milton, UK, 29 September 2008 – Genetix Group plc (AIM: GTX) (“Genetix” or the “Company”), the cancer diagnostic and biopharmaceutical technologies group, today announces the appointment of Dr. Stephen Game as Head of Research and Development, a newly created position aimed at further strengthening the Company’s focus on innovation, with effect from 3rd November [...]
September 26, 2008
Tecan, a global leader in laboratory automation and detection, has been granted Transcreener® Far Red FP validated status for its high-end multimode readers Infinite® M1000, Infinite F500 and Safire2™, by BellBrookLabs, LLC, a R&D-driven company and provider of enabling drug discovery screening tools for the pharmaceutical industry. All of Tecan’s high-end multimode microplate readers outlined [...]
September 26, 2008
- Development of next generation of High-Throughput Screening to accelerate the drug discovery process - Paris, September 26, 2008 - Sanofi-aventis announced today the launch of the dScreen Consortium, a research initiative conducted with RainDance Technologies , Inc., Lexington, Massachusetts, and Louis Pasteur University, Strasbourg, France, to develop the next generation of High-Throughput Screening (HTS) [...]
Fluidigm Withdraws Its Registration Statement for Initial Public Offering
September 26, 2008
Fluidigm Corporation today announced that due to the historic instability in the market, the company is withdrawing its registration statement for its initial public offering of shares of common stock. "We went out on September 5th with a very strong story and Fluidigm received a warm reception from the investment community. We explained how our [...]
RainDance Dedicates New Headquarters, Manufacturing Facility
September 26, 2008
LEXINGTON, Mass., Sept. 26 -- RainDance Technologies, Inc., a provider of innovative droplet-based microfluidic solutions for human health and disease research, today dedicated its new headquarters and operations building and unveiled its new RDT 1000 instrument. Keynoting the event was Sir Richard Roberts, 2003 Nobel Prize winner for physiology and medicine and Founder and Chief [...]
September 26, 2008
- Custom Chiral Separation Using Preparative Chromatography Eases and Speeds up Process Development; Rapidly and Efficiently Producing the Required Amount of Compounds for Early Development Phases While Being Cost Efficient at Industrial Scale POMPEY, France, September 26 -- Novasep, a global leader in advanced separation technologies, has recently added a state-of-the-art cGMP pilot scale continuous [...]
Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition
September 26, 2008
Invitrogen Corporation (NASDAQ:IVGN) today announced that the syndication of the financing relating to its proposed acquisition of Applied Biosystems announced on June 12, 2008 has been completed. Pricing for the $2.65 billion financing was in line with expected terms. The Term Loan A, in the amount of $1.4 billion, and the Revolving Credit Facility, in [...]
